All Phenotypes Nr4a2<tm1.1Pcn> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Nr4a2^tm1.1Pcn
targeted mutation 1.1, Pierre Chambon
MGI:4437024

Summary

6 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn	Not Specified	MGI:4437055
cn2	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Slc6a3^tm1(cre)Lrsn/Slc6a3^tm1(cre)Lrsn	involves: 129S1/Sv * 129X1/SvJ	MGI:4437054
cn3	Nr4a2^tm1.1Pcn/Nr4a2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺	involves: 129S1/Sv * 129X1/SvJ	MGI:5547375
cn4	Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn	involves: 129S1/Sv * 129X1/SvJ	MGI:5547376
cn5	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺	involves: C57BL/6 * C57BL/6NTac	MGI:5547377
cn6	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Tg(Lck-cre)1Jtak/0	Not Specified	MGI:5547378

Allelic Composition	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn
Genetic Background	Not Specified

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2^tm1.1Pcn mutation (0 available); any Nr4a2 mutation (40 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

nervous system phenotype ( J:157098 )

N	• injection of adenovirus expressing cre do not alter brain morphology, expression of midbrain dopamine neuron markers, or microglia activation

decreased dopaminergic neuron number ( J:157098 )

• mice injected with an adenovirus expressing cre exhibit a progressive decrease in dopaminergic neurons compared with wild-type mice

behavior/neurological

akinesia ( J:157098 )

• 3 to 4 months after injection with an adenovirus expressing cre, mice exhibit impaired performance in a stepping test compared with wild-type mice

homeostasis/metabolism

decreased dopamine level ( J:157098 )

• in the dorsolateral striatum and areas innervated by scattered ventral tegmental area of mice injected with an adenovirus expressing cre

Allelic Composition	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Slc6a3^tm1(cre)Lrsn/Slc6a3^tm1(cre)Lrsn
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2^tm1.1Pcn mutation (0 available); any Nr4a2 mutation (40 available)
Slc6a3^tm1(cre)Lrsn mutation (1 available); any Slc6a3 mutation (66 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality at weaning, complete penetrance ( J:157098 )

• mice do not survive beyond 3 weeks

• however, leaving pups with mothers improves perinatal survival beyond 3 weeks

nervous system

abnormal dopaminergic neuron morphology ( J:157098 )

• expression of midbrain dopamine neuron markers is lost compared to in wild-type mice

neuron degeneration ( J:157098 )

• mice exhibit a rapid loss of substantia nigra pars compacta cell bodies with only scattered ventral tegmental area neurons remaining compared with wild-type mice

behavior/neurological

decreased vertical activity ( J:157098 )

• at 4 and 14 months

decreased locomotor activity ( J:157098 )

hyperactivity ( J:157098 )

• L-DOPA-treated mice exhibit hyperactivity unlike similarly treated wild-type mice

increased stereotypic behavior ( J:157098 )

• L-DOPA-treated mice exhibit repetitive behaviors (including repetitive gnawing, excessive grooming, and self-injury) unlike similarly treated wild-type mice

homeostasis/metabolism

decreased dopamine level ( J:157098 )

• at P1, striatal dopamine levels are decreased to 14% of wild-type

• at P14, the ratio of homovanillic acid (HVA) to dopamine is increased indicating increased dopamine turnover compared to in wild-type mice

• at P60, striatal dopamine levels are almost completely lost unlike in wild-type mice

• at P60, dopamine levels are more severely decreased in the caudate putamen compared to in the nucleus accumbens

increased serotonin level ( J:157098 )

• serotonin levels in the caudate putamen and nucleus accumbens are increased compared to in wild-type mice

abnormal response/metabolism to endogenous compounds ( J:157098 )

• L-DOPA-treated mice exhibit hyperactivity and repetitive behaviors unlike similarly treated wild-type mice

growth/size/body

decreased body size ( J:157098 )

• at 2 months, mice left with their mothers after weaning are 40% smaller than wild-type mice

Allelic Composition	Nr4a2^tm1.1Pcn/Nr4a2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxp3^{tm4(YFP/icre)Ayr} mutation (2 available); any Foxp3 mutation (55 available)
Nr4a2^tm1.1Pcn mutation (0 available); any Nr4a2 mutation (40 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal regulatory T cell morphology ( J:205658 )

• Treg cells are not properly maintained

hematopoietic system

abnormal regulatory T cell morphology ( J:205658 )

• Treg cells are not properly maintained

Allelic Composition	Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn
Genetic Background	involves: 129S1/Sv * 129X1/SvJ

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal regulatory T cell morphology ( J:205658 )

• regulatory T cells are not properly maintained

abnormal regulatory T cell physiology ( J:205658 )

• slightly attenuated suppressive activity

• in a transfer model of colitis, regulatory T cells fail to inhibit wasting disease and colitis compared with wild-type cells

hematopoietic system

abnormal regulatory T cell morphology ( J:205658 )

• regulatory T cells are not properly maintained

abnormal regulatory T cell physiology ( J:205658 )

• slightly attenuated suppressive activity

• in a transfer model of colitis, regulatory T cells fail to inhibit wasting disease and colitis compared with wild-type cells

Allelic Composition	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺
Genetic Background	involves: C57BL/6 * C57BL/6NTac

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} mutation (2 available); any Gt(ROSA)26Sor mutation (944 available)
Nr4a2^tm1.1Pcn mutation (0 available); any Nr4a2 mutation (40 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal T-helper 1 cell differentiation ( J:205658 )

• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions following tamoxifen-treatment

abnormal T-helper 17 cell differentiation ( J:205658 )

• reduced under Th17-skewing conditions following tamoxifen-treatment

abnormal regulatory T cell morphology ( J:205658 )

• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions following tamoxifen-treatment

hematopoietic system

abnormal T-helper 1 cell differentiation ( J:205658 )

• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions following tamoxifen-treatment

abnormal T-helper 17 cell differentiation ( J:205658 )

• reduced under Th17-skewing conditions following tamoxifen-treatment

abnormal regulatory T cell morphology ( J:205658 )

• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions following tamoxifen-treatment

Allelic Composition	Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Tg(Lck-cre)1Jtak/0
Genetic Background	Not Specified

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr4a2^tm1.1Pcn mutation (0 available); any Nr4a2 mutation (40 available)
Tg(Lck-cre)1Jtak mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

neonatal lethality, incomplete penetrance ( J:205658 )

• more than half of mice

immune system

immune system phenotype ( J:205658 )

N	• surviving mice exhibit no auto-immune disease symptoms up to 4 months of age • mice exhibit normal numbers of regulatory T cells in the thymus and spleen

increased susceptibility to induced colitis ( J:205658 )

• DSS-treated mice exhibit accelerated body weight loss, severe intestinal inflammation, increased Th1 cells and attenuated increase of regulatory T cells in the colon and cecum lamina propria compared with control mice

abnormal T-helper 1 cell differentiation ( J:205658 )

• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions

abnormal T-helper 17 cell differentiation ( J:205658 )

• reduced under Th17-skewing conditions

increased CD4-positive, alpha-beta T cell number ( J:205658 )

• CD44highCD62Llow-activated and IFN-gamma CD4+ T cells

increased T-helper 1 cell number ( J:205658 )

• in DSS-treated mice

abnormal regulatory T cell morphology ( J:205658 )

• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions

decreased regulatory T cell number ( J:205658 )

• in DSS-treated mice

digestive/alimentary system

increased susceptibility to induced colitis ( J:205658 )

growth/size/body

increased susceptibility to weight loss ( J:205658 )

• accelerated in DSS-treated mice

hematopoietic system

abnormal T-helper 1 cell differentiation ( J:205658 )

• increased under Th1-, Th17- and induced regulatory T cell-skewing conditions

abnormal T-helper 17 cell differentiation ( J:205658 )

• reduced under Th17-skewing conditions

increased CD4-positive, alpha-beta T cell number ( J:205658 )

• CD44highCD62Llow-activated and IFN-gamma CD4+ T cells

increased T-helper 1 cell number ( J:205658 )

• in DSS-treated mice

abnormal regulatory T cell morphology ( J:205658 )

• reduced regulatory T cell differentiation under induced regulatory T cell-skewing conditions

decreased regulatory T cell number ( J:205658 )

• in DSS-treated mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/07/2024 MGI 6.23